Browsing by Author "Labieb, Fatma"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Global Trends of Monkeypox-Related Articles: A Bibliometric Analysis Over the Last Five Decades (1964 – July 14, 2022)
    (Elsevier, 2023) Kamal, Manar Ahmed; Farahat, Ramadan Abdelmoez; Awad, Ahmed K.; Tabassum, Shehroze; Labieb, Fatma; Bejan, Cosmin A.; Al-Tawfiq, Jaffar A.; Dhama, Kuldeep; Dergaa, Ismail; Medicine, School of Medicine
    Background: The first human monkeypox (MPX) case was identified in the Democratic Republic of Congo (DRC) in 1970 with an outbreak in 2010 and the first human MPX case in the UK in 2022. In this study, we conducted a bibliometric analysis of the literature on monkeypox based on the Web of Science Core Collection (WOSCC) of the Institute for Scientific Information (ISI) to identify relevant topics and trends in monkeypox research. Methods: We searched the Web of Science from 1964 until July 14, 2022, for all publications using the keywords "Monkeypox" and "Monkeypox virus." Results were compared using numerous bibliometric methodologies and stratified by journal, author, year, institution, and country-specific metrics. Results: Out of 1170 publications initially selected, 1163 entered our analysis, with 65.26 % (n = 759) being original research articles and 9.37 % (n = 109) being review articles. Most MPX publications were in 2010, with 6.02 % (n = 70), followed by 2009 and 2022 at 5.67 % (n = 66) each. The USA was the country with the highest number of publications, with n = 662 (56.92 %) of total publications, followed by Germany with n = 82 (7.05 %), the UK with n = 74 (6.36 %), and Congo with n = 65 (5.59 %). Journal of Virology published the highest number of MPX publications, followed by Virology Journal and Emerging Infectious Diseases with n = 52 (9.25 %), n = 43 (7.65 %), and n = 32 (5.69 %) publications, respectively. The top contributing institutions were the Centers for Disease Control and Prevention (CDC), the US Army Medical Research Institute of Infectious Diseases, and the National Institutes of Health (NIH)National Institute of Allergy and Infectious Diseases (NIAID). Conclusion: Our analysis provides an objective and robust overview of the current literature on MPX and its global trends; this information could serve as a reference guide for those aiming to conduct further MPX-related research and as a source for those seeking information about MPX.
  • Thumbnail Image
    Item
    Human monkeypox disease (MPX)
    (Department of Medicine and Surgery, University of Salern, 2022-09-01) Farahat, Ramadan Abdelmoez; Sah, Ranjit; El-Sakka, Amro A.; Benmelouka, Amira Yasmine; Kundu, Mrinmoy; Labieb, Fatma; Shaheen, Rahma Sameh; Abdelaal, Abdelaziz; Abdelazeem, Basel; Bonilla-Aldana, D. Katterine; Franco-Paredes, Carlos; Henao-Martinez, Andres F.; Garout, Mohammed A.; León-Figueroa, Darwin A.; Pachar, Monica; Suárez, José Antonio; Ramirez, Juan David; Paniz-Mondolfi, Alberto; Rabaan, Ali A.; Al-Tawfiq, Jaffar A.; Nishiura, Hiroshi; Ortiz-Martínez, Yeimer; Garcia-Robledo, Juan Esteban; Cimerman, Sergio; Barbosa, Alexandre Naime; Pagliano, Pasquale; Zambrano-Sanchez, Gabriela; Cardona-Ospina, Jaime A.; Bížová, Beatrice; Rodriguez-Morales, Alfonso J.; Medicine, School of Medicine
    Monkeypox is a rare viral infection, endemic in many central and western African countries. The last international outbreak of monkeypox reported outside Africa occurred back in 2003. However, monkeypox has reemerged at a global scale with numerous confirmed cases across the globe in 2022. The rapid spread of cases through different countries has raised serious concerns among public health officials worldwide prompting accelerated investigations aimed to identify the origins and cause of the rapid expansion of cases. The current situation is reminiscent of the very early stages of the still ongoing COVID-19 pandemic. Overlapping features between these, two seemingly alike viral entities include the possibility for airborne transmission and the currently unexplained and rapid spread across borders. Early recognition of cases and timely intervention of potential transmission chains are necessary to contain further outbreaks. Measures should include rapid and accurate diagnosis of cases meeting case definitions, active surveillance efforts, and appropriate containment of confirmed cases. Governments and health policymakers must apply lessons learned from previous outbreaks and start taking active steps toward limiting the recent global spread of monkeypox. Herein, we discuss the status of the current monkeypox outbreaks worldwide, the epidemiological and public health situation at a global scale and what can be done to keep at bay its further expansion and future global implications.